How to get ahead of winter blues: Montreal therapists suggest sleep, exercise and socializing - Montreal Gazette
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
While autumn in Montreal is a whimsical season characterized by crisp mornings, colourful foliage and pumpkins galore, for some it can also come with an underlying feeling of dread.
Another brutal winter is around the corner — a time when daylight is limited and people naturally gravitate indoors, resulting in lower energy and a change in moods.
This article is an excerpt. To read the full content, visit the original source. Montreal Gazette
Related articles
The unsung heroes: McMaster's student field therapists | Sports | thesil.ca - thesil.ca
The unsung heroes: McMaster's student field therapists | Sports |
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!